Phase 1 Study of MKC-1 in Patients With Advanced or Metastatic Solid Malignancies.

Trial Profile

Phase 1 Study of MKC-1 in Patients With Advanced or Metastatic Solid Malignancies.

Completed
Phase of Trial: Phase I

Latest Information Update: 01 Oct 2014

At a glance

  • Drugs MKC 1 (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Sponsors CASI Pharmaceuticals; EntreMed
  • Most Recent Events

    • 17 Dec 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 17 Dec 2009 Actual end date (Nov 2009) added as reported by ClinicalTrials.gov.
    • 15 Jul 2009 Actual initiation date changed from Apr 2008 to Mar 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top